Journals / Klinik Psikofarmakoloji Bülteni / 2012 / Cilt: 22 - Sayı: 2

Visual hallucinations associated with bupropion use: a case report

Bupropion kullanımıyla ilişkili görsel halüsinasyon: Bir olgu sunumu

Pages
187–189
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Unlike these side-effects,we present a case in which visual hallucinationsdeveloped during use of sustained-release bupropionin therapeutic doses.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bupropion is an antidepresant that acts as anorepinephrine and dopamine reuptake inhibitor andhas a favorable side-effect profile.
📊
Key Findings & Data:The most commonside-effects of this drug include insomnia, constipation,headache and dry mouth.
💡
Conclusion & Impact:Unlike these side-effects,we present a case in which visual hallucinationsdeveloped during use of sustained-release bupropionin therapeutic doses.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bupropion is an antidepresant that acts as anorepinephrine and dopamine reuptake inhibitor andhas a favorable side-effect profile. The most commonside-effects of this drug include insomnia, constipation,headache and dry mouth. Unlike these side-effects,we present a case in which visual hallucinationsdeveloped during use of sustained-release bupropionin therapeutic doses.

Özet

Bupropion; norepinefrin ve dopamin geri alım inhi bitörü olarak etki eden ve yan etki profili bakımındanoldukça güvenli sayılabilecek bir antidepresan ilaçtır.Bupropionun en sık görülen yan etkileri; uykusuzluk,konstipasyon, baş ağrısı ve ağız kuruluğu şeklindedir.Yazımızda bu yan etkilerden farklı olarak, terapötikdozda yavaş salınımlı bupropion kullanımı sırasındagörsel halüsinasyon ortaya çıkan bir olgu sunulacaktır.

🔖

Cite This Article

KORKMAZ, S., SAĞLAM, S., ATMACA, M., KULOĞLU, M. (2022). Visual hallucinations associated with bupropion use: a case report. Klinik Psikofarmakoloji Bülteni, Cilt: 22 - Sayı: 2, 187–189. https://ajindex.com/articles/574135

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, et al. Bupropion: A review of its mechanism of antideressant activity. J Clin Psychiatry 1995; 56(9):395-401. Papakostas GI. Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacol 2006; 16(6):391-402. Moreira R. The efficacy and tolerability of bupropion in the treatment of major depressive disorder. Clin Drug Investig 2011; 31 (Suppl.1):S5-S17. Dedeoğlu E, Bayram B, Kızıler AU, Dedeoğlu B. Bupropion HCl yavaş salınımlı formuna bağlı jeneralize tonik klonik nöbet. Klinik Psikofarmokoloji Bülteni - Bulletin of Clinical Psychopharmacology 2011; 21(4):362-3. Evren C. Sigarayı bırakma tedavisinde antidepresanların kullanımı: Bu tedavide Bupropion’un yeri. Klinik Psikofarmokoloji Bülteni - Bulletin of Clinical Psychopharmacology 2001; 11(3):198-211.
  2. Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT. Review of the pharmacology and clinical profile of Bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Reviews 2006; 12(3-4):178-207. American Psychiatric Association. Dignostic and Statistical Manual of Mental Disorders, 4th ed, rev. Washington, DC: American Psychiatric Association; 2000.
  3. Waibel KH, Katial RK. Serum sickness-like reaction and bupropion. J Am Acad Child Adolesc Psychiatry 2004; 43(5):509. Bobé F, Buil ME, Palacios L. Rhabdomyolysis connected with the use of bupropion. Scand J Prim Health Care 2004; 22(3):191-2.
  4. Surovik J, Riddel C, Chon SY. A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation. J Drugs Dermatol 2010; 9(8):1010-2.
  5. Thorpe EL, Pizon AF, Lynch MJ, Boyer J. Bupropion induced serotonin syndrome: a case report. J Med Toxicol 2010; 6(2):168- 71. Aggarwal A, Sharma RC. Bupropion-induced mania and hypomania: A report of two cases. J Neuropsychiatry Clin Neurosci 2011; 23(2):51-2.
  6. Hussain H, Butt MA. Bupropion-induced hypomania in a patient with unipolar depression. Aust N Z J Psychiatry 2008; 42(8):746. Golden RN, James SP, Sherer MA, Rudorfer MV, Sack DA, Potter WZ. Psychoses associated with bupropion treatment. Am J Psychiatry 1985; 142:1459-62.
  7. Holm KJ, Spencer CM. Bupropion: A review of its use in the management of smoking cessation. Drugs 2000; 59(4):1007-24.
  8. Ames D, Wirshing WC, Szuba MP. Organic mental disorders associated with bupropion in three patients. J Clin Psychiatry 1992; 53(2):53-5.
  9. Kroemer S, Kawohl W. Gustatory and olfactory hallucinations under therapeutic dosing of bupropion. J Neurop